Wealthspring Capital’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-59,360
Closed -$602K 158
2025
Q1
$602K Hold
59,360
0.93% 30
2024
Q4
$595K Buy
+59,360
New +$595K 0.9% 31

Other funds holding TDACU

Wealthspring Capital's TDACU Position: Q2 2025 in Review

Wealthspring Capital sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2025, closing a stake of 59,360 shares — an estimated $602K sold.

Wealthspring Capital first reported a position in TDACU in Q4 2024 and held it in 2 quarters. The position peaked at $602K in Q1 2025. 9 funds tracked by Wall St. Rank hold TDACU as of Q2 2025.

  • Wealthspring Capital reported no remaining Translational Development Acquisition Corp Units position as of Q2 2025 after selling out during the quarter.
  • Wealthspring Capital sold 59,360 Translational Development Acquisition Corp Units shares in Q2 2025, an estimated $602K.
  • Wealthspring Capital first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 2 quarters.
  • Wealthspring Capital's Translational Development Acquisition Corp Units position peaked at $602K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2025.

Based on Wealthspring Capital's 13F filing for Q2 2025, filed 6 Aug 2025.